Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQIndustrialsIndustrial - MachinerySnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|---|---|
| Annual ending 2026-12-31 | ||
| Revenue | — | 29.51M |
| EPS | — | -0.03 |
Management figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Improve cash flow from operations from negative $852,000 in Q1 2026 | The company aims to improve operating income and cash flow. | Improving | cash flow remains negative or worsens over next 4 quarters | Cash from operations: $-425,000 FY2026-Q2; GAAP. Published target: cash flow from operations improves toward positive. Target period is not explicitly aligned with this observation. Source published Aug 12, 2026-425,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Execute $1.8 million cost reduction plan in 2026 | It plans $1.8 million in cost cuts in 2026. | Under Pressure | cost savings fall significantly below $1.8 million in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Improve operating income from negative $1.8 million in Q1 2026 | The company aims to improve operating income and cash flow. | Improving | operating income remains negative or worsens over next 4 quarters | Operating income: $-1.559M FY2026-Q2; GAAP. Published target: operating income improves toward break-even or better. Target period is not explicitly aligned with this observation. Source published Aug 12, 2026-1,559,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 2245ad00-0eb8-4b0c-972b-e2c6ee4eb05d. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Limit revenue decline from expected -43% in 2026 | A supporting condition in CVD Equipment Corp's published investment case. The stated target is revenue decline less than -20% YoY in 2026. | Broken | revenue decline exceeds -43% in FY26 | Revenue growth: -61.79% FY2026-Q2; GAAP. Published target: revenue decline less than -20% YoY in 2026. Target period is not explicitly aligned with this observation. Source published Aug 12, 2026-61.7883 percent · calculatedSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 2245ad00-0eb8-4b0c-972b-e2c6ee4eb05d. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 9, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment represents a turnaround situation. CVV is currently facing weak financial performance and high risk, but it is positioned in a cheap valuation relative to its peers, suggesting potential for recovery if management can execute its strategic priorities effectively.
The market appears to have priced in a low level of confidence in CVV's ability to improve its financial performance. The valuation is considered cheap compared to peers, but there is an expectations gap indicating that investors may not fully believe in a turnaround.
Fundamentals are likely to remain weak in the near term, with a high probability of missing earnings expectations. Management's recent focus on cost reduction and strategic shifts may take time to show positive results.
The thesis hinges on management's ability to execute its priorities, particularly the transition to a new business focus and cost reductions. Additionally, the performance of sector bellwethers will be crucial, as their results could impact CVV's momentum.
In the next 1 to 3 years, CVV faces significant challenges but has potential if management can navigate its strategic shifts effectively. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.